Department of Medicine (S.S., A.F.B., K.A.R.) and Center for Atrial Fibrillation (W.I.S., K.G.T., J.R., M.B., B.B., P.T., M.B., M.C., T.D., T.C., D.C., M.K., B.D.L., O.M.W., A.A.H.), Section of Cardiac Pacing and Electrophysiology, Heart and Vascular Institute, Cleveland Clinic, OH.
Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005785. doi: 10.1161/CIRCEP.117.005785.
Atrial fibrillation recurrence after initial long-term success of catheter ablation has been described, yet not well studied. We assessed the electrophysiological findings and outcomes of repeat ablation procedures in this setting.
Between 2000 and 2015, 10 378 patients underwent atrial fibrillation ablation and were enrolled in a prospectively maintained data registry. From this registry, we included all 137 consecutive patients who had initial long-term success, defined as freedom from recurrent arrhythmia for >36 months off antiarrhythmics, then underwent repeat ablation for recurrent atrial fibrillation. The median arrhythmia-free period that defined long-term success was 52 months (41-68 months). In redo ablations, reconnection along at least one of the pulmonary veins (PVs) was found in 111 (81%) patients. Reconnection along a left superior, left inferior, right superior, and right inferior PV was found in 64%, 62%, 50%, and 54% of patients, respectively, and were reisolated. Additional non-PV ablations were performed in 127 (92.7%) patients: posterior wall (46%), septal to right PVs (49%), superior vena cava (35%), roof lines (52%), and cavotricuspid isthmus (33%). After a median follow-up of 17 months (5-36.9 months), 103 patients (75%) were arrhythmia free (79 off antiarrhythmics, 24 on antiarrhythmics).
PV reconnection is the most common electrophysiological finding in patients with atrial fibrillation recurrence after long-term success, but with lower rates than what had been reported for early recurrences. In our experience, repeat ablations in this setting involve complex ablation approaches to reisolate the PVs and modify the atrial substrate and are associated with good success rates.
初始长期成功的导管消融后心房颤动复发已有描述,但研究不足。我们评估了在此背景下重复消融程序的电生理发现和结果。
在 2000 年至 2015 年期间,10378 例患者接受了心房颤动消融,并被纳入一个前瞻性维护的数据登记处。在此登记处中,我们纳入了所有 137 例连续患者,这些患者最初长期成功,定义为在停用抗心律失常药物 >36 个月后无心律失常复发,然后因心房颤动复发而进行重复消融。定义长期成功的无心律失常期中位数为 52 个月(41-68 个月)。在再次消融中,111 例(81%)患者至少一条肺静脉(PV)出现再连接。左侧上、下、右侧上和右侧下 PV 再连接分别见于 64%、62%、50%和 54%的患者,并对其进行了再隔离。127 例(92.7%)患者进行了额外的非 PV 消融:后壁(46%)、PV 至间隔(49%)、上腔静脉(35%)、房顶线(52%)和三尖瓣峡部(33%)。中位随访 17 个月(5-36.9 个月)后,103 例(75%)患者无心律失常(79 例停用抗心律失常药物,24 例服用抗心律失常药物)。
在长期成功后心房颤动复发的患者中,PV 再连接是最常见的电生理发现,但与早期复发时报告的发生率相比,其发生率较低。根据我们的经验,在此情况下的重复消融涉及到复杂的消融方法,以重新隔离 PV 并修饰心房基质,且成功率较高。